Nikki A. Evensen
Research Subjects
Nikki A. Evensen has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- William L. Carroll
Perlmutter Cancer Center, NYU Langone Health, New York, USA
15 shared publications - Aristotelis Tsirigos
Department of Pathology, New York University Grossman School of Medicine, New York, USA
13 shared publications - David Trent Teachey
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
13 shared publications - Elizabeth Raetz
Department of Pediatrics, NYU Langone Medical Center, New York, USA
13 shared publications - Sonali Narang
Perlmutter Cancer Center, NYU Langone Health, New York, USA
13 shared publications - Matthew T. Witkowski
Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, USA
12 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
Supplementary Fig. 4 shows the B-ALL specific compartment switches and transcription factor expression.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
Supplementary Fig. 4 shows the B-ALL specific compartment switches and transcription factor expression.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
Supplementary Fig. 1 shows the soring strategy and Hi-C quality control.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
Supplementary Fig. 1 shows the soring strategy and Hi-C quality control.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
Supplementary Fig. 5 shows the Validation of B-ALL specific 3D rewired genes.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
Supplementary Fig. 5 shows the Validation of B-ALL specific 3D rewired genes.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
Supplementary Fig. 2 shows the Genomic loci displaying compartment switching in B-cell development.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
Supplementary Fig. 2 shows the Genomic loci displaying compartment switching in B-cell development.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Data from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
The identification of molecular subgroups of pediatric B-cell acute lymphocytic leukemia (B-ALL) has proven to be a powerful tool in understanding disease pathogenesis and treatment stratification. Studies have suggested aberrant transcription factor function and epigenetic regulation can explain differences between B-ALL subtypes; however, the impact of 3D genome reorganization remains unclear. In this study, we used in situ Hi-C and RNA sequencing to profile the chromatin architectural landscape in healthy B-cell progenitors and B-ALL patient samples harboring prognostically relevant structural variations, including ETV6::RUNX1, KMT2A::AFF1, and BCR::ABL. We showed that B-ALLs undergo subtype-specific changes that, in part, reflect the differentiation stage of the disease and that they acquire aberrant chromatin configurations that allow the expression of oncogenic drivers. One such driver, ERG, displayed increased interactivity and expression in ETV6::RUNX1 B-ALL, and evidence suggests that it plays a role in regulating survival and differentiation. Overall, these results underscore the essential role of 3D nuclear organization in acute leukemia.Significance:Our integrative analyses of 3D chromatin architecture, accessibility, and gene expression in normal and malignant human B cells revealed an evolution of 3D genome architecture and associated transcription programs that may drive the differentiation of normal B cells as well as the transformation of B-ALL subtypes.See related commentary by Gruber, p. 509
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
The identification of molecular subgroups of pediatric B-cell acute lymphocytic leukemia (B-ALL) has proven to be a powerful tool in understanding disease pathogenesis and treatment stratification. Studies have suggested aberrant transcription factor function and epigenetic regulation can explain differences between B-ALL subtypes; however, the impact of 3D genome reorganization remains unclear. In this study, we used in situ Hi-C and RNA sequencing to profile the chromatin architectural landscape in healthy B-cell progenitors and B-ALL patient samples harboring prognostically relevant structural variations, including ETV6::RUNX1, KMT2A::AFF1, and BCR::ABL. We showed that B-ALLs undergo subtype-specific changes that, in part, reflect the differentiation stage of the disease and that they acquire aberrant chromatin configurations that allow the expression of oncogenic drivers. One such driver, ERG, displayed increased interactivity and expression in ETV6::RUNX1 B-ALL, and evidence suggests that it plays a role in regulating survival and differentiation. Overall, these results underscore the essential role of 3D nuclear organization in acute leukemia.Significance:Our integrative analyses of 3D chromatin architecture, accessibility, and gene expression in normal and malignant human B cells revealed an evolution of 3D genome architecture and associated transcription programs that may drive the differentiation of normal B cells as well as the transformation of B-ALL subtypes.See related commentary by Gruber, p. 509
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
Supplementary Fig. 3 shows the mutation and structural variant analysis in B-ALL samples.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
Supplementary Fig. 3 shows the mutation and structural variant analysis in B-ALL samples.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
Supplementary Fig. 6 shows the profiling the 3D TAD rewiring in KMT2Ar and ETV6::RUNX1 B-ALL.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 6 from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
Supplementary Fig. 6 shows the profiling the 3D TAD rewiring in KMT2Ar and ETV6::RUNX1 B-ALL.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
Supplementary Fig. 7 shows ERG and downstream target gene expression in healthy B-cell progenitors and B-ALL.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
Supplementary Fig. 7 shows ERG and downstream target gene expression in healthy B-cell progenitors and B-ALL.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 8 from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
Supplementary Fig. 8 shows the impact of ERG in ETV6::RUNX1 B-ALL.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 8 from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
Supplementary Fig. 8 shows the impact of ERG in ETV6::RUNX1 B-ALL.
- Open Access
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Tables S1-S9 from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
Supplementary Table S1-Samples Supplementary Table S2-Compartment Switches in normal B-cells Supplementary Table S3-ATAC Sequencing Quality Metrics Supplementary Table S4-Compartment Switches in KMT2Ar Supplementary Table S5-Compartment Switches in ETV6::RUNX1 Supplementary Table S6-TAD activity in KMT2Ar Supplementary Table S7-TAD activity in ETV6::RUNX1 Supplementary Table S8-HOMER analysis in KMT2Ar Supplementary Table S9-HOMER analysis in ETV6::RUNX1.
- 1 July 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables S1-S9 from 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia
Supplementary Table S1-Samples Supplementary Table S2-Compartment Switches in normal B-cells Supplementary Table S3-ATAC Sequencing Quality Metrics Supplementary Table S4-Compartment Switches in KMT2Ar Supplementary Table S5-Compartment Switches in ETV6::RUNX1 Supplementary Table S6-TAD activity in KMT2Ar Supplementary Table S7-TAD activity in ETV6::RUNX1 Supplementary Table S8-HOMER analysis in KMT2Ar Supplementary Table S9-HOMER analysis in ETV6::RUNX1.